Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) EBT (2016 - 2025)

HealthLynked (HLYK) has disclosed EBT for 10 consecutive years, with -$736654.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 62.67% to -$736654.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.6 million, a 42.12% increase, with the full-year FY2024 number at -$6.1 million, down 69.66% from a year prior.
  • EBT was -$736654.0 for Q3 2025 at HealthLynked, down from -$682780.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of -$161370.0 in Q3 2023 to a low of -$7.8 million in Q1 2021.
  • A 5-year average of -$1.6 million and a median of -$1.2 million in 2024 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 1248.37% in 2021, then skyrocketed 89.49% in 2023.
  • HealthLynked's EBT stood at -$2.0 million in 2021, then tumbled by 103.55% to -$4.1 million in 2022, then skyrocketed by 68.46% to -$1.3 million in 2023, then increased by 4.32% to -$1.2 million in 2024, then skyrocketed by 40.12% to -$736654.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's EBT are -$736654.0 (Q3 2025), -$682780.0 (Q2 2025), and -$931365.0 (Q1 2025).